Answers are grounded in this paper and cite their sources.
During the course of studies of hypertensive patients, including a double blind study, observations were made concerning the diabetogenic activity of benzothiadiazine derivatives. This activity was observed to occur in nonobese patients without a family history of diabetes as well as in obese hypertensives with such a family history. These observations suggest that benzothiadiazines should not be given to young or middle-aged hypertensives in whom there is a lengthy life expectancy and for whom alternative hypotensive therapy is feasible.
No takes yet. Share an insight, caveat, or question.
Frederick Wolff (1963) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: